Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsTrendsHealth

Scientists, drugmakers and traders react to AstraZeneca's COVID-19 vaccine trial pause

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," AstraZeneca said in an emailed statement.

September 09, 2020 / 09:47 PM IST

AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker's shares as the move was seen as dimming prospects for an early rollout.

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," AstraZeneca said in an emailed statement.

Below are reactions from scientists, drugmakers and stock market traders and analysts to the news:

SCIENTISTS: